A/Prof Guy Toner
Honorary (Principal Fellow)
The Sir Peter MacCallum Department of Oncology
186 Scholarly works
3 Projects
HIGHLIGHTS
2026
Journal article
The utility of genomics and functional imaging to predict sunitinib pharmacokinetics and pharmacodynamics: The predict SU study
DOI: 10.1002/bcp.704312023
Journal article
Patterns of Relapse in Australian Patients with Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations
DOI: 10.1200/OP.23.001912023
Journal article
Pembrolizumab and denosumab in clear cell renal cell carcinoma (ccRCC): A phase II trial (KeyPAD, ANZUP1601)
DOI: 10.1016/j.annonc.2023.09.11162022
Journal article
Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up
DOI: 10.1186/s40644-022-00496-w2022
Journal article
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres
DOI: 10.1111/bju.156482021
Conference Proceedings
Exploring the role for FDG-PET/CT in testicular seminoma at diagnosis and during active surveillance across the disease spectrum
2017
Research Grant
Combination of Radionuclide 177lu-Psma Therapy With Pembrolizumab in Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc)
RECENT SCHOLARLY WORKS
2021
Journal article
Clinical utility of FDG PET-CT in stage 1 and advanced testicular seminoma.
DOI: 10.1200/JCO.2021.39.15_suppl.50272021
Conference Proceedings
P3BEP (ANZUP 1302): An international randomized phase III trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumors (GCTs).
DOI: 10.1200/JCO.2021.39.6_suppl.TPS3902021
Conference Proceedings
Denosumab and pembrolizumab in clear cell renal carcinoma (KEYPAD): A phase II trial (ANZUP1601).
DOI: 10.1200/JCO.2021.39.6_suppl.TPS3672020
Conference Proceedings
P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs)
DOI: 10.1200/jco.2026.44.7_suppl.tps623
RECENT PROJECTS
2010
Research Grant
Novel Methods to Predict the Pharmacology and Effect of Anticancer Drugs
2008
Research Grant
Accelerated First Line Chemotherapy for Advanced Germ Cell Tumours